Statin therapy with ezetimibe or niacin in high-risk patients

New England Journal of Medicine

Volumn 361, Issue 22, 2009, Pages 2180-2183

  Kastelein, John J P ^a   Bots, Michiel L ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

ACUTE CORONARY SYNDROME; ADD ON THERAPY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CLINICAL TRIAL; DRUG RELEASE; ECHOGRAPHY; EDITORIAL; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RENAL PROTECTION;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CAROTID ARTERIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NIACIN; RESEARCH DESIGN; TUNICA INTIMA; TUNICA MEDIA;

EID: 72049126375     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0908841     Document Type: Editorial

References (11)

1. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-2346 (Pubitemid 30013066)
2. Kastelein JJ, Akdim F, Stroes ES, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-1443 [Erratum, N Engl J Med 2008;358: 1977.]
3. Fleg JL, Mete M, Howard BV, et al. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol 2008;52:2198-2205
4. Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-1356
5. Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009;361:2113-2122
6. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-7. [Errata, Circulation 2004;110: 3615, 2005;111(24):e446.]
7. Crouse JR III, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-1353 (Pubitemid 46513235)
8. van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006;59:1102-1109 (Pubitemid 44374315)
9. Barrett-Connor E. Looking for the pony in the HERS data: Heart and Estrogen/progestin Replacement Study. Circulation 2002;105:902-903
10. Pocock S, White I. Trials stopped early: too good to be true? Lancet 1999;353:943-944
11. Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-2209